Enterococcus faecalis
(Redirected from Enterococcus)
Background
Antibiotic Sensitivities[1]
Category | Antibiotic | Enterococcus faecalis |
Penicillins | Penicillin G | S |
Penicillin V | S | |
Methicillin | R | |
Nafcillin/Oxacillin | R | |
Cloxacillin/Diclox. | R | |
Amino-Penicillins | AMP/Amox | S |
Amox-Clav | S | |
AMP-Sulb | S | |
Anti-Pseudomonal Penicillins | Ticarcillin | I |
Ticar-Clav | I | |
Pip-Tazo | S | |
Piperacillin | S | |
Carbapenems | Doripenem | I |
Ertapenem | R | |
Imipenem | S | |
Meropenem | I | |
Aztreonam | R | |
Fluroquinolones | Ciprofloxacin | U |
Ofloxacin | U | |
Pefloxacin | R | |
Levofloxacin | S | |
Moxifloxacin | S | |
Gemifloxacin | S | |
Gatifloxacin | S | |
1st G Cephalo | Cefazolin | R |
2nd G. Cephalo | Cefotetan | R |
Cefoxitin | R | |
Cefuroxime | R | |
3rd/4th G. Cephalo | Cefotaxime | R |
Cefizoxime | R | |
CefTRIAXone | R | |
Ceftaroline | S | |
CefTAZidime | R | |
Cefepime | R | |
Oral 1st G. Cephalo | Cefadroxil | R |
Cephalexin | R | |
Oral 2nd G. Cephalo | Cefaclor/Loracarbef | R |
Cefproxil | R | |
Cefuroxime axetil | R | |
Oral 3rd G. Cephalo | Cefixime | R |
Ceftibuten | R | |
Cefpodox/Cefdinir/Cefditoren | R | |
Aminoglycosides | Gentamicin | SS |
Tobramycin | SS | |
Amikacin | SS | |
Chloramphenicol | I | |
Clindamycin | R | |
Macrolides | Erythromycin | R |
Azithromycin | R | |
Clarithromycin | R | |
Ketolide | Telithromycin | I |
Tetracyclines | Doxycycline | R |
Minocycline | R | |
Glycylcycline | Tigecycline | S |
Daptomycin | S | |
Glyco/Lipoclycopeptides | Vancomycin | S |
Teicoplanin | S | |
Telavancin | S | |
Fusidic Acid | S | |
Trimethoprim | S | |
TMP-SMX | X3 | |
Urinary Agents | Nitrofurantoin | S |
Fosfomycin | S | |
Other | Rifampin | I |
Metronidazole | R | |
Quinupristin dalfoppristin | R | |
Linezolid | S | |
Colistimethate | R |
Key
- S susceptible/sensitive (usually)
- I intermediate (variably susceptible/resistant)
- R resistant (or not effective clinically)
- S+ synergistic with cell wall antibiotics
- U sensitive for UTI only (non systemic infection)
- X1 no data
- X2 active in vitro, but not used clinically
- X3 active in vitro, but not clinically effective for Group A strep pharyngitis or infections due to E. faecalis
- X4 active in vitro, but not clinically effective for strep pneumonia
Table Overview
|
See Also
References
- ↑ Sanford Guide to Antimicrobial Therapy 2014